Oral delivery of messenger RNA is one of the capabilities of Matinas BioPharma's technology. BioNTech will explore that feature among others under a new research alliance with Matinas, a clinical-stage biotech that also has an ongoing collaboration with Genentech.
TSX Venture Exchange has a strong history of helping early stage health and life sciences companies raise patient capital for research and development purposes.
The DNA currently used in genetic medicines research is synthesized by chemical methods. Ansa Biotechnologies employs faster and less expensive enzymes-based technology, and the startup has raised capital to scale up operations as it prepares to launch its service.
By Andrey Ostrovsky and Everett Crosland Monday, April 11, 2022 6:50 PM
Our analysis demonstrates that CMS's coverage processes for breakthrough devices demonstrate product class and disease state disparities. These disparities contradict mental health parity statute, CMS Administrator Brooks-LaSure's focus on equity, and President Biden's charge to improve brain health.
By Michael Schroeder Monday, April 11, 2022 5:53 PM
The Series B funding round was led by Enhanced Healthcare Partners. Hoboken, New Jersey-based Vytalize has grown its patient base 150% year-over-year and is now partnered with 280 primary care practices across 16 states, according to the company.
By Dr. Katherine H. Saunders Monday, April 11, 2022 12:00 PM
Obesity is a disease, and America's healthcare providers and hospital systems must be part of changing how we treat it. That means many of us in the health ecosystem must reexamine how we view patients with excess weight.
No comments